Correction: Infliximab for pediatric patients with Crohn's disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan.

ABSTRACT: [This corrects the article DOI: 10.1371/journal.pone.0201956.].

SUBMITTER: Tajiri H 

PROVIDER: S-EPMC9017882 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature